InMed Pharmaceuticals INM
NASDAQ INM
$1.31 -0.02 (-1.35%)
As of: Sep 9, 2026 · 12:30 PM EDT

InMed Pharmaceuticals (INM) Income from Discontinued Operations (2025 - 2026)

InMed Pharmaceuticals (INM) posted Income from Discontinued Operations of -$174585.0 for Q1 2026, down 224.14% on a QoQ basis from -$53861.0 in Q1 2025, and down 224.14% year-over-year from $140635.7 in Q1 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

InMed Pharmaceuticals (INM) Income from Discontinued Operations (2025 - 2026) Analysis & Trends

InMed Pharmaceuticals has reported Income from Discontinued Operations for 2 years, with the latest figure at -$174585.0 in Q1 2026.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Corning 145.60 Bn 143.09 Bn 1.63 Bn -
2 Ati 28.49 Bn 27.71 Bn 309.80 Mn -
3 Qnity Electronics 26.28 Bn 25.32 Bn 666.00 Mn -
4 International Flavors & Fragrances 21.55 Bn 20.98 Bn 853.00 Mn 31.00 Mn
5 DuPont de Nemours 17.59 Bn 15.85 Bn 639.00 Mn -44.00 Mn
6 Avery Dennison 12.97 Bn 12.74 Bn 729.40 Mn -
7 Solstice Advanced Materials 10.11 Bn 9.36 Bn 370.00 Mn -
8 Element Solutions 8.83 Bn 8.64 Bn 334.00 Mn -
9 Eastman Chemical 7.87 Bn 7.17 Bn 560.00 Mn -
10 InMed Pharmaceuticals 5.31 Mn 69,625.35 - -174,585.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -174,585.00
Mar 31, 2025 -53,861.00